Glomerular and tubular dysfunction in children with congenital cyanotic heart disease: Effect of palliative surgery

American Journal of the Medical Sciences

Volumn 325, Issue 3, 2003, Pages 110-114

  Awad, Hesham ^a   El Safty, Ibrahim ^b,c   Abdel Gawad, Moustafa ^a   El Said, Salwa ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b Ain Shams University   (Egypt)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

Children; Congenital cyanotic heart disease (CCHD); Hematocrit; Leucine aminopeptidase; N acetyl D glucosaminidase; Oxygen saturation; Palliative surgery; 1 microglobulin

Indexed keywords

ALPHA 1 MICROGLOBULIN; CYTOSOL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE;

ARTICLE; CHILD; CONTROLLED STUDY; CYANOSIS; CYANOTIC HEART DISEASE; DISEASE DURATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; GLOMERULOPATHY; HEMATOCRIT; HUMAN; INFANT; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MAJOR CLINICAL STUDY; OXYGEN SATURATION; PALLIATIVE THERAPY; PROTEIN URINE LEVEL; RISK FACTOR; TREATMENT OUTCOME; TUBULAR DYSFUNCTION; URINARY EXCRETION;

EID: 0037345778     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200303000-00002     Document Type: Article

References (23)

1. Burke JR, Glasgow EF, McCredie DA, et al. Nephropathy in congenital cyanotic heart disease. Clin Nephrol 1977;7:38-42.
2. Flanagan MF, Hourihan M, Keane JF. Incidence of renal dysfunction in adults with cyanotic congenital heart disease. Am J Cardiol 1991;68:403-6.
3. Dittrich S, Kurschat K, Dahnert I, et al. Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catheterization in patients with congenital cyanotic heart disease. Cardiol Young 2000;10:8-14.
4. Dittrich S, Haas NA, Buhrer C, et al. Renal impairment in patients with long-standing congenital cyanotic heart disease. Acta Pediatr 1998;87:949-54.
5. Burlet A, Drukker A, Guignard JP. Renal function in congenital cyanotic heart disease. Nephron 1999;81:296-300.
6. Akita H, Matsuoa S, Kuroda Y. Nephropathy in patients with cyanotic congenital heart disease. Tokushima J Exp Med 1993;40:47-53.
7. Krull F, Ehrich JHH, Wurster U, et al. Renal involvement in patients with cyanotic congenital heart disease. Acta Pediatr Scand 1991;80:1214-9.
8. Rebel W, Bertsch T, Bode G, et al. Enzymuria as indicator of renal pathomorphology. In: Jung K, Mattenheimer H, Búrchardt U, editors. Urinary enzymes in clinical and experimental medicine. Berlin: Springer-Verlag; 1992. p. 43-72.
9. Mueller PW, Lash LH, Price RG, et al. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. I. Categories of tests for detecting effects of nephrotoxins. Ren Fail 1997;19:505-21.
10. Zuppi C, Baroni S, Scribano D, et al. Choice of time for urine collection for detecting early kidney abnormalities in hypertensives. Ann Clin Biochem 1995;32:373-8.
11. Watanabe N, Kamei S, Ohkubo A, et al. Urinary protein as measured with a pyrogallol red-molybdata complex, manually and in a Hitachi 726 automated analyzer. Clin Chem 1986;32:1551-4.
12. Josch W, Dubach DU. Urine-arylamidase. Z Klin Chem 1967;5:59-63.
13. Thomas GH. β-D-Galactosidase in human urine: deficiency in generalized gangliosidosis. J Lab Clin Med 1969;74:725-31.
14. Bartels H, Bohmer M, Heieli C. Serum kreatininebestimmung ohne enteiweissen. Clin Chim Acta 1972;37:193-7.
15. Lemann J Jr., Dowmans BT. Proteinuria in health and disease assessed by measuring the urinary protein/creatinine ratio. Clin Chem 1987;33:297-9.
16. Woolerton J, Jary DR, Dunn PJ, et al. Urine albumin/creatinine ration and clinical correlates in a diabetic population. N Z Med J 1987;100:130-4.
17. Jung K. Enzyme activities in urine. How should we express their excretion? Eur J Clin Chem Clin Biochem 1991;29:725-9.
18. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. Cardiol Clin 1993;11:689-9.
19. Hagley MT, Murphy DP, Mullins D, et al. Decline in creatinine clearance in a patient with glomerulomegaly associated with a congenital cyanotic heart disease. Am J Kidney Dis 1992;20:177-9.
20. Meessen H, Litton MD. Morphology of the kidney in morbus caeruleus. Arch Pathol 1953;56:480-7.
21. Guyton AR, Hall JE. Textbook of medical physiology, 9th ed. Philadelphia: WB Saunders; 1996. p. 324-5.
22. DeJong PE, Weening JJ, Donker AJM, et al. The effect of phlebotomy on renal function and proteinuria in a patient with congenital cyanotic heart disease. Nephron 1983;33:225-6.
23. Wilcox CS, Payne J, Harrison DW. Renal function in patients with chronic hypoxemia and cor pulmonale following reversal of polycythemia. Nephron 1982;30:173-7.